GeneralConnection.com ➔ Dictionary
Dictionary Search

haemophilia b

Synonyms

Noun

1. hemophilia B

2. haemophilia B, Christmas disease, hemophilia, haemophilia, bleeder's disease

Usage
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors - Business Wire
Pfizer receives EC approval for Hympavzi to treat haemophilia - Yahoo
Explainer: Why Is Hemophilia B Called Christmas Disease? - Global Biotechnology Company
How durable is gene therapy for haemophilia B? - Nature
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
Single-Dose Gene Therapy Shows Promising Safety, Efficacy, and Patient-Reported Outcomes in Hemophilia B - Docwire News
EAHAD 2026: Nine-Year Outcomes of Gene Therapy - EMJ
Gene therapy can help reduce joint bleeds in hemophilia B: New data - Hemophilia News Today
Building safeguards for gene therapy in haemophilia - The Lancet
Optimization of hemophilia B treatment via population PK modeling of rIX-FP, including a 3-week regimen - Frontiers
First subject dosed in Be Biopharma’s trial of haemophilia B therapy - Clinical Trials Arena
Hemophilia B gene therapy demonstrates long-term success - St. Jude Children's Research Hospital
Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials - Nature
4 Things to Expect for the Future of Hemophilia Treatment - Docwire News
Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
New gene therapy reduces bleeding rates for hemophilia B patients - Hemophilia News Today
Exploring gene editing as a potential therapeutic strategy for hemophilia - Frontiers
Marstacimab Superior to On-Demand Prophylaxis for Hemophilia A, B, With Inhibitors - Docwire News
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B - The New England Journal of Medicine
Exploring Eptacog Beta Dosing in Patients With Hemophilia A or B - Docwire News
Patients With Hemophilia Face Significant Burden Despite Treatment Type or Disease Severity - Docwire News
Marstacimab in the treatment of patients with hemophilia A and B - Via Medica Journals
Phase 3 Analysis: Concizumab Noninferior to Prior Prophylaxis in Hemophilia A, B, Without Inhibitors - Docwire News
Pfizer’s Hympavzi significantly reduces bleeds in haemophilia patients - PMLiVE
ASH: CSL proves efficacy of hemophilia B gene therapy Hemgenix holds up after 5 years - Fierce Pharma
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors - Business Wire
First German haemophilia B patient receives gene therapy HEMGENIX - PharmaTimes
(marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need - Business Wire
Wolfgang Miesbach: New Study on AAV5 Antibodies in Haemophilia B Gene Therapy - Oncodaily
Five-year study confirms durable efficacy of etranacogene dezaparvovec - PharmaTimes
First-in-human trial of hemophilia B treatment BE-101 starts dosing - Hemophilia News Today
Hemophilia B gene therapy benefits last more than a decade: Study - Hemophilia News Today
Patient in Germany gets hemophilia B gene therapy Hemgenix - Hemophilia News Today
Hemophilia B Pipeline 2026 Report Highlights Next-Gen Gene Therapies, FDA Advances, and Clinical Momentum Across Novo Nordisk, Pfizer, Sanofi & Emerging Biotechs | DelveInsight - Barchart.com
Netherlands Temporarily Includes Hympavzi in Basic Package for Hemophilia A & B - NAVLIN DAILY
Tailored collagen binding of albumin-fused hyperactive coagulation factor IX dictates in vivo distribution and functional properties - Nature
Hull teenager first to be treated with new haemophilia drug - BBC
NICE recommends weekly injection for severe haemophilia B - The Pharmaceutical Journal
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors - PR Newswire
Fidanacogene Elaparvovec for Hemophilia B — A Multiyear Follow-up Study - The New England Journal of Medicine
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations - Managed Healthcare Executive
How to Plan for Emergencies When You Have Hemophilia B - Everyday Health
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B - PharmTech.com
China Explores Weight-Based Pricing for First Domestic Hemophilia B Gene Therapy - NAVLIN DAILY
Novo Nordisk’s Alhemo approved by FDA for expanded haemophilia use - PMLiVE
CSL Behring Signs Letter of Intent with pan-Canadian Pharmaceutical Alliance (pCPA) for Public Reimbursement of HEMGENIX® (etranacogene dezaparvovec), the First Gene Therapy for Hemophilia B - Yahoo Finance
Spotlight on the ISTH Hemophilia Treatment Guidelines and Alternate Recommendations - Hematology Advisor
Haemophilia gene therapy patients thriving over a decade after treatment | UCL News - UCL - UCL | University College London
Hemophilia gene therapy: A new era of treatment and the obstacles ahead - Drug Discovery News
Extended hemophilia half-life products aid care, but raise costs - Hemophilia News Today
Hemophilia prognosis: Life expectancy and outlook - Hemophilia News Today
One dose of gene therapy gives years of relief from blood disorder - Nature
Systemic lupus erythematosus caused acquired hemophilia B without evidence of factor IX inhibitors - Wiley Online Library
Expanding Alhemo to hemophilia without inhibitors recommended - Hemophilia News Today
EVOLVING THE TREATMENT LANDSCAPE WITH THE FIRST THERAPY APPROVED FOR PEOPLE WITH HEMOPHILIA A AND B WITH OR WITHOUT INHIBITORS - AJMC
G-BA Rates “Considerable” Added Benefit of Alhemo for Hemophilia B Patients - NAVLIN DAILY
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B - The New England Journal of Medicine
How Fitusiran Changes the Treatment Landscape in Hemophilia: Guy Young, MD - AJMC
NHS treats first haemophilia B patient with gene therapy - Progress Educational Trust
Real-world Impact of Gene Therapy: A Patient Story from New Jersey - Global Biotechnology Company
Concizumab approved to prevent or reduce the frequency of bleeding episodes in people aged 12 years and older with haemophilia A or B with inhibitors - GOV.UK
FDA expands approvals for Novartis lipid drug, Novo haemophilia prophylatic - FirstWord Pharma
First Patient in Germany Treated With Hemgenix for Hemophilia B - NAVLIN DAILY
CSL’s haemophilia therapy shows durable five-year benefits in landmark trial results - BiotechDispatch
The National “New Methods” Decision Forum in Norway recommends CSL’s gene therapy HEMGENIX® for adults with severe or moderately severe haemophilia B without a history of Factor IX inhibitors - Mynewsdesk
Switching to Extended Half-Life Therapies Improves Hemophilia Care, but Raises Short-Term Costs - Managed Healthcare Executive
Lighting up the library for World Haemophilia Day 2026 - Birmingham City Council
How pioneering gene therapy changed the life of the first man in Wales to receive it - Nation.Cymru
First gene therapy to treat haemophilia B - European Medicines Agency (EMA)
Haemophilia A vs B: Which is more severe? Here’s what sets them apart - TheHealthSite
CDC Hemophilia Mutation Projects (CHAMP and CHBMP) - Centers for Disease Control and Prevention | CDC (.gov)
Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A - Citeline News & Insights
First NHS patient given world's most expensive drug that costs £2.6 million per dose - LADbible
Phase 1–2 Trial of AAVS3 Gene Therapy in Patients with Hemophilia B - The New England Journal of Medicine
With hemophilia B, a lifetime of worry eased with one infusion - Penn Today
Non-replacement therapy for people with haemophilia B: another step towards health equity - The Lancet
CSL Behring treats two patients with gene therapy for haemophilia B - Clinical Trials Arena
NMPA approves BBM and Takeda China’s haemophilia B therapy - Pharmaceutical Technology
Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment - Docwire News
European regulatory authority adopts positive opinion for Novo Nordisk’s Alhemo® (concizumab), recommending label expansion to treat haemophilia A and B without inhibitors - Yahoo Finance UK
First hemophilia B patients in Denmark treated with Hemgenix –... - Hemophilia News Today
A New Era of Hemophilia Care: Perspectives from Denmark - Global Biotechnology Company
Transformational therapy cures haemophilia B - BBC
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant - The New England Journal of Medicine
Groundbreaking treatment for haemophilia administered in Wales for first time - Nation.Cymru
Therapeutic efficacy in a hemophilia B model using a biosynthetic mRNA liver depot system - Nature
Man battling disease since he was a baby incredibly no longer needs weekly treatment - Wales Online
Novo Nordisk’s Alhemo Recommended for Expanded Use in Europe for Haemophilia A and B - Insider Monkey
Belief, Takeda’s home-grown haemophilia B gene therapy gains nod in China - FirstWord Pharma
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors - The New England Journal of Medicine
Breaking ground in haemophilia B gene therapy: insights from the HOPE-B trial and beyond - The Lancet
Real Stories from People Living with Hemophilia - Centers for Disease Control and Prevention | CDC (.gov)
CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice - Nature
UK Approves Marstacimab for Severe Haemophilia A or B - Medscape
Gene therapy trial markedly cuts bleeding risk in haemophilia B patients - The Guardian
Haemophilia - The Lancet
Freeline Therapeutics doses first subject in haemophilia B therapy trial - Clinical Trials Arena
Gene Therapy for Hemophilia B Could Lower Health Plans’ Budget Over Time - AJMC
uniQure announces FDA approval of first gene therapy for adults with hemophilia B - uniqure.gcs-web.com
Pfizer's weekly haemophilia drug backed for NHS use - pharmaphorum
Foreign Language Equivalents
Foreign Language Equivalents of 'haemophilia b'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
haemophiila b,   haemophili b,   hae,ophilia b,   haemphilia b,   haemophulia b,   haemophilua b,   haemmophilia b,   haeomphilia b,   haemiphilia b,   hamophilia b,   haemophilia ,   haemophilis b,   haaemophilia b,   hsemophilia b,   haemohpilia b,   haeemophilia b,   haemophila b,   haemo[hilia b,   haemophilia v,   haenophilia b,   haemophhilia b,   haemophilia bb,   haemoohilia b,   hhaemophilia b,   jaemophilia b,   heamophilia b,   haemophiliab ,   haemopgilia b,   haemophilai b,   haemopjilia b,   haeophilia b,   gaemophilia b,   haemopilia b,   haemophiia b,   haemophiliia b,   haemopphilia b,   haemophillia b,   hemophilia b,   haemophikia b,   haemophilia b,   haemoophilia b,   haemophlia b,   haempohilia b,   haemopihlia b,   aemophilia b,   haempphilia b,   hameophilia b,   ahemophilia b,   haemophili ab,   haemophiilia b,   haemophilia n,   haemophiliab,   hawmophilia b,   haemophiliaa b,   haemophliia b,   haemohilia b,   harmophilia b,   haemopholia b,   haemophiloa b,   haemophi;ia b
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z